"The introduction of innovative technology into cross-border capital investment" investment model has won high praise from governments all over China!
Infinity Equity Management Co., Ltd. (Infinity Capital) is an affiliate of Infinity Group, a leading investment management company from Israel. Infinity Capital operates the core businesses in Greater China, which mainly involves a domestic RMB fund and cross-border M&A. Infinity Capital has offices in 12 cities across China, covering the five major business areas, North China, East China, South China, Southwest, Hong Kong as well as overseas. With the advantage of having resources in Israel, we insist on introducing cross-border capital investment in innovative technology, and we are committed to building important ties and bridges of cooperation in science, technology and innovation between China and Israel.
At present, the investment fund of Infinity in China has nearly 8 billion RMB invested in TMT (science and technology, media, communications), health and life sciences, energy conservation and environmental protection, precision manufacturing and new materials and other areas of the key layout. In the last two years alone, Infinity Capital has had four successful listings: Vincent Medical (HK01612), AsymChem (002821), Huati Technology (603679), Liancheng Precision (002921). Golden Point Gardens, Hongtu Separator, IOPtima has been acquired by Meishang Ecology (300495). Jinguan Electrical (300510), Kanghong Pharmaceutical (002773) respectively which has achieved good results. Additionally, at present, a number of portfolio companies are preparing to IPO.